| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
|
Clemons, Mark
|
|
|
142 |
C |
p. 132-140
|
artikel
|
| 2 |
Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma
|
Shao, Fei
|
|
|
142 |
C |
p. 123-131
|
artikel
|
| 3 |
Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
|
Wyld, Lynda
|
|
|
142 |
C |
p. 48-62
|
artikel
|
| 4 |
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)
|
Nemes, Karolina
|
|
|
142 |
C |
p. 112-122
|
artikel
|
| 5 |
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses
|
Schubert, Nil A.
|
|
|
142 |
C |
p. 1-9
|
artikel
|
| 6 |
Corrigendum to ‘5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy’ [the Eur J Canc (2014) 1370–1381]
|
Wachowska, Malgorzata
|
|
|
142 |
C |
p. 150-151
|
artikel
|
| 7 |
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study
|
Desilets, Antoine
|
|
|
142 |
C |
p. 83-91
|
artikel
|
| 8 |
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
|
Buti, Sebastiano
|
|
|
142 |
C |
p. 18-28
|
artikel
|
| 9 |
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
|
Dafni, U.
|
|
|
142 |
C |
p. 63-82
|
artikel
|
| 10 |
Erratum to “Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings” [Eur J Cancer 136 (September 2020) 159−168]
|
Castañón, Eduardo
|
|
|
142 |
C |
p. 152-153
|
artikel
|
| 11 |
Hepatic arterial infusion of chemotherapy as an option in a multimodal treatment of metastatic squamous cell carcinoma of the anus
|
Dall’Armellina, François
|
|
|
142 |
C |
p. 147-149
|
artikel
|
| 12 |
Impact of systemic corticosteroids on survival outcomes in immune checkpoint inhibitor–induced gastroenterocolitis
|
Thompson, Leah L.
|
|
|
142 |
C |
p. 143-146
|
artikel
|
| 13 |
Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic
|
Stadler, Rudolf
|
|
|
142 |
C |
p. 38-47
|
artikel
|
| 14 |
Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia
|
Hong, Angela M.
|
|
|
142 |
C |
p. 10-17
|
artikel
|
| 15 |
Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program
|
Albiges, Laurence
|
|
|
142 |
C |
p. 102-111
|
artikel
|
| 16 |
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications
|
Restaino, Stefano
|
|
|
142 |
C |
p. 29-37
|
artikel
|
| 17 |
Successful toxicity reduction during delayed intensification in the non-high-risk arm of Malaysia-Singapore Acute Lymphoblastic Leukaemia 2010 study
|
Oh, Bernice L.Z.
|
|
|
142 |
C |
p. 92-101
|
artikel
|
| 18 |
Treading carefully in de-escalation for bone-targeted agents – is less more, after all?
|
Patrikidou, Anna
|
|
|
142 |
C |
p. 141-142
|
artikel
|
Tijdschrift beschrijving